title: Heparin-induced tumour bleed.
abstract: Patients with gliomas are at risk for deep vein thrombosis and thromboembolic events, and pharmacological prophylaxis may be indicated. This recommendation needs to be weighed against the risk of spontaneous haemorrhage from certain brain tumours. A patient, who was hemiparetic owing to a high-grade glioma and was started on heparin prophylaxis, developed a tumour bleed. The relevant issues are briefly discussed.
authors.affiliation: Department of Neurosurgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India. venkateshmadhugiri@gmail.com
authors.forename: Venkatesh S
authors.initials: VS
authors.lastname: Madhugiri
authors.forename: Anita
authors.initials: A
authors.lastname: Mahadevan
authors.forename: Sudheer Kumar
authors.initials: SK
authors.lastname: Gundamaneni
authors.forename: Manish
authors.initials: M
authors.lastname: Singh
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications*; D005260:Female; D005910:Glioma / Q000150:complications*; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin